PE-22-28
PE-22-28
Bionk Peptides delivers high-performance research compounds engineered with uncompromising attention to detail. Every vial is produced to exceed 99% purity and supplied in lyophilised powder form, preserving molecular integrity while ensuring optimal stability and precision in application. Bionk Peptides are commitment to elevated research performance. For laboratory research only. Not for human use.
Couldn't load pickup availability
Description
PE-22-28
PE-22-28 is a synthetic seven-amino-acid peptide derived from the PACAP-related signalling pathway and is primarily investigated in experimental neuroscience research. It has attracted interest for its potential role in neuroprotective and antidepressant-related mechanisms observed in preclinical models.
Laboratory research has explored PE-22-28 in relation to neuronal signalling, cellular stress responses, oxidative stress and pathways involved in neuronal survival. Studies also examine its potential influence on molecular processes associated with neuroplasticity and cellular resilience.
PE-22-28 is therefore of interest in neuroscience, molecular biology and peptide research, particularly for investigating signalling mechanisms involved in neuronal function and cellular protection.
Laboratory Research Data Analysis
- Synthetic seven-amino-acid peptide
- Derived from a region of the PACAP-related signalling pathway
- Studied for its interaction with cellular signalling mechanisms
- Investigated in neuroscience and neurobiology research
- Research focuses on neuroprotective and cellular stress-response pathways
- Studied in experimental models of neuronal signalling and cellular survival
- Used to investigate mitochondrial function and oxidative-stress pathways
